Publication:
Extramedullary relapsed multiple myeloma treatment with 177Lu-Labeled CXCR4 endoradiotherapy and dosimetric results

Simple item page
dc.contributor.coauthorUçar, Burcu
dc.contributor.coauthorWester, Hans-Juergen
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorDemirkol, Mehmet Onur
dc.contributor.kuauthorFerhanoğlu, Ahmet Burhan
dc.contributor.kuauthorÖzkan, Ahu
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:06:38Z
dc.date.issued2021
dc.description.abstractWe created our first national clinical protocol of Lu-177-CXCR4 therapy for patient who have failed to respond to current therapy options. We also calculated the kidney, liver, and tumor dosimetry. The kidney's mean absorbed dose was calculated to be 0.45 Gy/GBq, the calculated radiation absorbed dose of the liver was 0.63 Gy/GBq, and the radiation absorbed doses of the tumors vary between 9.2 and 82 Gy/GBq. Lu-177-CXCR4 therapy produced a promising clinical response in our patient in acceptable radiation dose limits as a treatment option in heavily pretreated patients with advanced multiple myeloma.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.issue8
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipKoc University Hospital This work was supported by the İstanbul American Hospital and Koc University Hospital.
dc.description.volume46
dc.identifier.doi10.1097/RLU.0000000000003705
dc.identifier.eissn1536-0229
dc.identifier.issn0363-9762
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85110666378
dc.identifier.urihttps://doi.org/10.1097/RLU.0000000000003705
dc.identifier.urihttps://hdl.handle.net/20.500.14288/9006
dc.identifier.wos669618500019
dc.keywordsMultiple myeloma
dc.keywordsCXCR4
dc.keywordsEndoradiotherapy
dc.keywordsPentixather
dc.keywordsDosimetry
dc.language.isoeng
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofClinical Nuclear Medicine
dc.subjectRadiology
dc.subjectNuclear medicine
dc.subjectMedical imaging
dc.titleExtramedullary relapsed multiple myeloma treatment with 177Lu-Labeled CXCR4 endoradiotherapy and dosimetric results
dc.typeOther
dc.type.otherEditorial material
dspace.entity.typePublication
local.contributor.kuauthorDemirkol, Mehmet Onur
local.contributor.kuauthorÖzkan, Ahu
local.contributor.kuauthorFerhanoğlu, Ahmet Burhan
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext